Tilarginine

N/A

Report date: 2025/07/31 18:03:02
NME

Base Information

Drug NameTilarginine
Drug Alias NameL-NMMANG-monomethyl-L-arginine
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide synthase inhibitors
TargetsNitric oxide synthase
Therapy Area/IndicationsMetastatic breast cancerTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHouston Methodist Hospital
China Registration ClassN/A

Develop Information

Active CompaniesNova Pharmaceuticals Australasia Pty LtdGalera Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A